STOCK TITAN

Organogenesis Holdings Inc. to Participate in the ICR Conference 2021

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Organogenesis Holdings (Nasdaq: ORGO) has announced its participation in the ICR Conference 2021, scheduled to take place virtually from January 11th to 14th. Management will engage in a fireside chat on January 14th at 1:45 p.m. Eastern Time. A live audio webcast of the presentation will be accessible via the company’s Investor Relations page, with an archive available for replay for 30 days post-conference. Organogenesis specializes in regenerative medicine, offering solutions in advanced wound care and sports medicine.

Positive
  • None.
Negative
  • None.

CANTON, Mass., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today announced that company management will attend the ICR Conference 2021, which is being held virtually from January 11th-14th. Management will participate in a fireside chat on Thursday, January 14th at 1:45 p.m. Eastern Time.

A live audio webcast of the conference presentation will be accessible by visiting the “Upcoming Events” section on the “Investor Relations” page of Organogenesis’s website www.organogenesis.com. An archive of the webcast will be available for replay following the conference for approximately 30 days.

About Organogenesis Holdings Inc.

Organogenesis Holdings Inc. is a leading regenerative medicine company offering a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine. Organogenesis’s comprehensive portfolio is designed to treat a variety of patients with repair and regenerative needs. For more information, visit www.organogenesis.com.


FAQ

When is Organogenesis participating in the ICR Conference 2021?

Organogenesis will participate in the ICR Conference 2021 from January 11th to 14th, with a fireside chat on January 14th at 1:45 p.m. Eastern Time.

How can I access Organogenesis's presentation at the ICR Conference?

You can access the live audio webcast of Organogenesis's presentation on the 'Investor Relations' page of their website.

Is there a replay available for the Organogenesis presentation at ICR Conference?

Yes, an archive of the webcast will be available for replay for approximately 30 days after the conference.

What does Organogenesis specialize in?

Organogenesis specializes in regenerative medicine, focusing on advanced wound care and surgical biologics.

What is the stock symbol for Organogenesis?

The stock symbol for Organogenesis is ORGO.

Organogenesis Holdings Inc.

NASDAQ:ORGO

ORGO Rankings

ORGO Latest News

ORGO Stock Data

522.35M
74.82M
43.44%
48.28%
7.39%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
CANTON